|
|
|
CEA Carcinoembryonic Antigen Rapid Test Strip
(Whole Blood/Serum/Plasma) is an emerging aid and a strong addition to your line of Tumor Marker products.
Sensitivity: >99.9%, Specificity: 99.8%
For detailed sales support information, please contact us directly.
(TCE-401/402)
The CEA Carcinoembryonic Antigen Rapid Test Device (Whole Blood/Serum/Plasma) is an emerging aid and a strong addition to your line of Tumor Marker products.
Sensitivity: >99.9%, Specificity: 99.8%
For detailed sales support information, please contact us directly.
|
 |
|
AFP Alpha-Fetoprotein Rapid Test Device (TAF-402)
AFP Rapid Test Device (Whole Blood/Serum/Plasma) can detect antibodies to Alpha-Fetoprotein (AFP) in whole blood, serum or plasma to screen early tumors in people at high risk for liver cancer. This can help determine the possibility of hepatocellular carcinoma. AFP has also been used in the detection of fetal open neural tube defects.
For detailed sales support information, please contact us directly.
|
 |
|
FOB One Step Fecal Occult Blood Test Device (Feces)
Catalog No:TFO-602
Most of diseases can cause hidden blood in the stool. In the early stages, gastrointestinal problems such as colon cancer, ulcers, polyps, colitis, diverticulitis, and fissures may not show any visible symptoms, only occult blood. Traditional guaiac-based method lacks sensitivity and specificity, and has diet-restriction prior to the testing.1,2
The FOB One Step Fecal Occult Blood Test Device (Feces) is a rapid test to qualitatively detect low levels of fecal occult blood in feces. The test uses double antibody sandwich assay to selectively detect as low as 50 ng/mL of hemoglobin or 6 g hemoglobin/g feces. In addition, unlike the guaiac assays, the accuracy of the test is not affected by the diet of the patients.
|
|
PSA Prostate Specific Antigen Semi-Quantitative Ultra Rapid Test Device (Whole Blood/Serum/Plasma)
Catalog No: TPS-U402
40 Tests
The PSA Prostate Specific Antigen Semi-Quantitative Ultra Rapid Test Device (Whole Blood/Serum/Plasma) is
a semi-quantitative, membrane based immunoassay for the detection of PSA in whole blood, serum or plasma. The membrane is pre-coated with PSA antibodies on the test line region. During testing, specimen reacts with the particle coated with anti-PSA antibody. The mixture migrates upward on the membrane chromatographically by capillary action to react with anti-PSA antibodies on the membrane and generate a colored line. A test line intensity weaker than the reference line indicates that the PSA level in the specimen is between 3-10 ng/mL. A test line intensity equal or close to the reference line indicates that the PSA level in the specimen is approximately 10 ng/mL. A test line intensity stronger than the reference line indicates that the PSA level in the specimen is above 10 ng/mL. To serve as a procedural control, a colored line will always appear in the control line region indicating that proper volume of specimen has been added and membrane wicking has occurred.
Relative Sensitivity: 98.7% (95.4%-99.8%) Relative Specificity: 98.5% (96.3%-99.6%)
Relative Accuracy: 98.6% (97.0%-99.5%) 95% Confidence Interval
|
|
|
|
|
| | |
|